Curtis Holt

4.4k total citations
46 papers, 3.3k citations indexed

About

Curtis Holt is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Curtis Holt has authored 46 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hepatology, 25 papers in Epidemiology and 18 papers in Surgery. Recurrent topics in Curtis Holt's work include Liver Disease and Transplantation (18 papers), Organ Transplantation Techniques and Outcomes (17 papers) and Hepatitis C virus research (17 papers). Curtis Holt is often cited by papers focused on Liver Disease and Transplantation (18 papers), Organ Transplantation Techniques and Outcomes (17 papers) and Hepatitis C virus research (17 papers). Curtis Holt collaborates with scholars based in United States, Germany and Austria. Curtis Holt's co-authors include Ronald W. Busuttil, Hasan Yersiz, Douglas G. Farmer, Leonard I. Goldstein, Paul Martin, Sammy Saab, Sue V. McDiarmid, Rafik M. Ghobrial, James F. Markmann and Jonathan R. Hiatt and has published in prestigious journals such as Hepatology, Annals of Surgery and The American Journal of Gastroenterology.

In The Last Decade

Curtis Holt

45 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Curtis Holt United States 26 2.5k 1.9k 1.5k 734 213 46 3.3k
Carlos Margarit Spain 28 2.1k 0.8× 966 0.5× 1.8k 1.2× 656 0.9× 215 1.0× 100 2.8k
Paul McMaster United Kingdom 30 2.4k 1.0× 1.3k 0.7× 2.2k 1.5× 658 0.9× 265 1.2× 75 3.4k
Bo S. Husberg United States 34 2.9k 1.2× 1.4k 0.7× 3.1k 2.1× 1.1k 1.4× 406 1.9× 123 4.4k
Hiroto Egawa Japan 30 1.8k 0.7× 1.1k 0.6× 1.6k 1.1× 733 1.0× 202 0.9× 118 3.0k
Federico Villamil United States 19 1.9k 0.8× 1.5k 0.8× 923 0.6× 364 0.5× 193 0.9× 47 2.5k
G. Blumhardt Germany 23 1.3k 0.5× 627 0.3× 1.2k 0.8× 605 0.8× 129 0.6× 99 2.2k
Rachel Pedersen United States 20 1.6k 0.6× 1.9k 1.0× 1.2k 0.8× 445 0.6× 62 0.3× 39 2.9k
Mitchell L. Shiffman United States 24 2.7k 1.1× 1.8k 0.9× 1.8k 1.2× 253 0.3× 679 3.2× 43 3.6k
Stephen V. Lynch Australia 29 1.8k 0.7× 553 0.3× 2.2k 1.5× 854 1.2× 575 2.7× 125 3.5k
David Levi United States 39 1.5k 0.6× 847 0.4× 2.9k 2.0× 1.6k 2.2× 451 2.1× 177 4.4k

Countries citing papers authored by Curtis Holt

Since Specialization
Citations

This map shows the geographic impact of Curtis Holt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Curtis Holt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Curtis Holt more than expected).

Fields of papers citing papers by Curtis Holt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Curtis Holt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Curtis Holt. The network helps show where Curtis Holt may publish in the future.

Co-authorship network of co-authors of Curtis Holt

This figure shows the co-authorship network connecting the top 25 collaborators of Curtis Holt. A scholar is included among the top collaborators of Curtis Holt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Curtis Holt. Curtis Holt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holt, Curtis. (2017). Overview of Immunosuppressive Therapy in Solid Organ Transplantation. Anesthesiology Clinics. 35(3). 365–380. 67 indexed citations
2.
Cheng, Elaine, Sammy Saab, Curtis Holt, & Ronald W. Busuttil. (2015). Paritaprevir/ritonavir/ombitasvir and dasabuvir for the treatment of chronic hepatitis C virus infection. Expert Opinion on Pharmacotherapy. 16(18). 2835–2848. 9 indexed citations
3.
Campsen, Jeffrey, Michael A. Zimmerman, James F. Trotter, et al.. (2013). Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues. Liver Transplantation. 19(9). 1020–1029. 26 indexed citations
4.
Agopian, Vatche G., Fady M. Kaldas, Johnny C. Hong, et al.. (2012). Liver Transplantation for Nonalcoholic Steatohepatitis. Annals of Surgery. 256(4). 624–633. 175 indexed citations
5.
Saab, Sammy, Ayman Ibrahim, Zobair M. Younossi, et al.. (2005). MELD fails to measure quality of life in liver transplant candidates. Liver Transplantation. 11(2). 218–223. 94 indexed citations
6.
Lucey, Michael R., Manal F. Abdelmalek, Darla K. Granger, et al.. (2005). A Comparison of Tacrolimus and Cyclosporine in Liver Transplantation: Effects on Renal Function and Cardiovascular Risk Status. American Journal of Transplantation. 5(5). 1111–1119. 73 indexed citations
7.
Saab, Sammy, Scott Comulada, Jonathan R. Hiatt, et al.. (2005). Mortality predictors in liver transplant recipients with recurrent hepatitis C cirrhosis. Liver International. 25(5). 940–945. 14 indexed citations
8.
Markmann, James F., Joseph W. Markmann, Niraj M. Desai, et al.. (2003). Operative Parameters That Predict the Outcomes of Hepatic Transplantation. Journal of the American College of Surgeons. 196(4). 566–572. 35 indexed citations
9.
Farmer, Douglas G., Dean M. Anselmo, R. Mark Ghobrial, et al.. (2003). Liver Transplantation for Fulminant Hepatic Failure. Annals of Surgery. 237(5). 666–676. 131 indexed citations
10.
Anselmo, Dean M., Rafik M. Ghobrial, Michael Weaver, et al.. (2002). New Era of Liver Transplantation for Hepatitis B. Annals of Surgery. 235(5). 611–620. 82 indexed citations
11.
Ghobrial, Rafik M., James F. Markmann, Curtis Holt, et al.. (2002). Pretransplant Model to Predict Posttransplant Survival in Liver Transplant Patients. Annals of Surgery. 236(3). 315–323. 135 indexed citations
12.
Ghobrial, Rafik M., Charles Lassman, Curtis Holt, et al.. (2001). A 10-Year Experience of Liver Transplantation for Hepatitis C: Analysis of Factors Determining Outcome in Over 500 Patients. Annals of Surgery. 234(3). 384–394. 193 indexed citations
13.
14.
Ghobrial, Rafik M., Douglas G. Farmer, Angeles Baquerizo, et al.. (1999). Orthotopic Liver Transplantation for Hepatitis C. Annals of Surgery. 229(6). 824–824. 147 indexed citations
15.
Holt, Curtis, et al.. (1998). Mycophenolate Mofetil. BioDrugs. 10(5). 373–384. 4 indexed citations
16.
Busuttil, Ronald W. & Curtis Holt. (1998). Tacrolimus is superior to cyclosporine in liver transplantation. Transplantation Proceedings. 30(5). 2174–2178. 22 indexed citations
17.
Markowitz, Jay S., Paul Martin, Andrew Conrad, et al.. (1998). Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology. 28(2). 585–589. 389 indexed citations
18.
Rosen, Hugo R., C R Shackleton, Sue V. McDiarmid, et al.. (1997). Causes of graft loss following liver transplantation for chronic hepatitis C. Transplantation Proceedings. 29(1-2). 526–528. 7 indexed citations
19.
Rossi, Stephen J., et al.. (1997). Mycophenolate Mofetil. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(6). 1178–1197. 88 indexed citations
20.
Jurim, Oded, Paul Martin, D. J. Winston, et al.. (1996). Failure of ganciclovir prophylaxis to prevent allograft reinfection following orthotopic liver transplantation for chronic hepatitis B infection. Liver Transplantation and Surgery. 2(5). 370–374. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos Margarit Breakdown of academic impact, for papers by Paul McMaster Breakdown of academic impact, for papers by Bo S. Husberg Breakdown of academic impact, for papers by Hiroto Egawa Breakdown of academic impact, for papers by Federico Villamil Breakdown of academic impact, for papers by G. Blumhardt Breakdown of academic impact, for papers by Rachel Pedersen Breakdown of academic impact, for papers by Mitchell L. Shiffman Breakdown of academic impact, for papers by Stephen V. Lynch Breakdown of academic impact, for papers by David Levi
Rankless by CCL
2026